Table 3 Subjects' characteristics and linear correlation analyses between circulating baseline omentin-1 concentrations and baseline parameters in women.
From: Circulating omentin concentration increases after weight loss
Women (n = 17) | |||||
|---|---|---|---|---|---|
Baseline | After weight loss | P | r* | p* | |
Age (years) | 43.3 ± 15.6 | 0.2 | 0.4 | ||
Body Mass Index (kg/m 2 ) | 33.8 ± 6.45 | 29.2 ± 5.1 | <0.001 | -0.69 | 0.002 |
Body Weight (kg) | 87.7 ± 17.4 | 75.6 ± 13.4 | <0.001 | -0.64 | 0.006 |
Fat mass (%) | 47.6 ± 5.7 | 40.8 ± 6.8 | <0.001 | -0.63 | 0.007 |
Waist (cm) | 101.5 ± 12.9 | 93.6 ± 14.06 | <0.001 | -0.44 | 0.08 |
Hip (cm) | 114.2 ± 12.2 | 104.8 ± 10.2 | <0.001 | -0.67 | 0.003 |
Waist to hip ratio | 0.88 ± 0.07 | 0.89 ± 0.08 | <0.001 | 0.13 | 0.6 |
Fasting glucose (mmol/l) | 5.04 ± 0.6 | 5.01 ± 0.38 | 0.047 | -0.07 | 0.8 |
Fasting triglycerides (mmol/l) | 1.06 ± 0.45 | 0.92 ± 0.36 | 0.001 | 0.1 | 0.7 |
HDL-cholesterol (mmol/l) | 1.5 ± 0.35 | 1.37 ± 0.27 | 0.47 | 0.21 | 0.4 |
LDL-cholesterol (mmol/l) | 3.1 ± 0.86 | 2.7 ± 0.6 | 0.001 | 0.35 | 0.2 |
Total cholesterol (mmol/l) | 5.06 ± 0.97 | 4.5 ± 0.57 | <0.001 | 0.43 | 0.09 |
Fasting insulin (mU/l) | 12.03 ± 9.6 | 9.6 ± 7.4 | 0.05 | -0.64 | 0.005 |
HOMA value | 2.54 ± 2.2 | 2 ± 1.6 | 0.05 | -0.55 | 0.02 |
Circulating Leptin (ng/ml) | 32.5 ± 7.8 | 12.8 ± 3.8 | <0.001 | -0.74 | 0.001 |
Circulating omentin-1 (ng/ml) | 41.1 ± 8.3 | 50.2 ± 7.6 | 0.001 | ||